Discover 3 SEHK Growth Companies With High Insider Ownership

In This Article:

As global markets navigate a complex landscape marked by economic uncertainties and shifting investor sentiment, the Hong Kong market has experienced its share of volatility, with the Hang Seng Index recently facing significant declines. Despite these challenges, growth companies with high insider ownership continue to capture investor interest due to their potential for resilience and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

Laopu Gold (SEHK:6181)

36.4%

33.2%

Akeso (SEHK:9926)

20.5%

53%

Fenbi (SEHK:2469)

33.1%

22.4%

Zylox-Tonbridge Medical Technology (SEHK:2190)

18.8%

69.8%

Pacific Textiles Holdings (SEHK:1382)

11.2%

37.7%

DPC Dash (SEHK:1405)

38.1%

104.2%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

13.9%

109.2%

Beijing Airdoc Technology (SEHK:2251)

29.4%

93.4%

Zhejiang Leapmotor Technology (SEHK:9863)

15%

69.7%

MicroTech Medical (Hangzhou) (SEHK:2235)

25.8%

105%

Click here to see the full list of 47 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Beauty Farm Medical and Health Industry

Simply Wall St Growth Rating: ★★★★★☆

Overview: Beauty Farm Medical and Health Industry Inc. operates in the healthcare sector, focusing on medical and health services, with a market cap of HK$4.02 billion.

Operations: The company's revenue is derived from several key segments: Aesthetic Medical Services (CN¥851.81 million), Subhealth Medical Services (CN¥125.69 million), Beauty and Wellness Services - Direct Stores (CN¥1.14 billion), and Beauty and Wellness Services - Franchisee and Others (CN¥131.48 million).

Insider Ownership: 33.9%

Earnings Growth Forecast: 20.2% p.a.

Beauty Farm Medical and Health Industry shows strong growth potential with forecasted earnings growth of 20.2% annually, outpacing the Hong Kong market. Recent half-year results reported sales of CNY 1.14 billion, a year-over-year increase, indicating solid revenue momentum. Despite no significant insider trading activity recently, high insider ownership aligns management interests with shareholders. The company trades significantly below estimated fair value, suggesting potential undervaluation amid expected robust profit expansion over the next three years.